9602:TSEToho Co., Ltd. Analysis
Data as of 2026-06-13 - not real-time
SAR 9.24
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading below its short‑term moving average while also under the longer‑term average, reinforcing bearish momentum. The 14‑day RSI sits near the midpoint, indicating neither overbought nor oversold conditions. MACD shows a slight bullish histogram despite the line remaining negative, suggesting limited short‑term upside potential. Price is hovering near a well‑defined support level, with resistance only a modest distance away. Volume has been trending lower, which diminishes the conviction behind any breakout. Overall technicals point to a cautious stance with limited upside in the near term.
Fundamentally, the company posted a sharp decline in revenue and continues to generate negative operating margins, highlighting operational challenges. Profitability is thin, and cash flow from operations is negative, raising concerns about sustainable earnings. The price‑to‑earnings multiple is markedly higher than the industry average, implying that the stock is priced for strong growth that is not evident in the financials. With no dividend and a low payout capacity, income‑focused investors have little appeal. The beta is low, indicating limited market‑wide volatility, yet the stock’s own price volatility is elevated, adding to risk. Given the bearish technical picture, high valuation, and weak fundamentals, the outlook remains tentative.
Fundamentally, the company posted a sharp decline in revenue and continues to generate negative operating margins, highlighting operational challenges. Profitability is thin, and cash flow from operations is negative, raising concerns about sustainable earnings. The price‑to‑earnings multiple is markedly higher than the industry average, implying that the stock is priced for strong growth that is not evident in the financials. With no dividend and a low payout capacity, income‑focused investors have little appeal. The beta is low, indicating limited market‑wide volatility, yet the stock’s own price volatility is elevated, adding to risk. Given the bearish technical picture, high valuation, and weak fundamentals, the outlook remains tentative.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- bearish price trend with price below short‑term moving average
- proximity to support and limited upside
- decreasing trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- significant revenue decline and negative operating margins
- valuation far above industry peers
- absence of dividend and weak cash flow
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- potential for strategic restructuring in asset‑management segment
- low beta suggesting limited systematic risk
- high price volatility and liquidity constraints
Key Metrics & Analysis
Financial Health
Revenue Growth-48.10%
Profit Margin6.99%
P/E Ratio46.2
ROE1.81%
ROA1.57%
Debt/Equity1.88
P/B Ratio0.8
Op. Cash FlowSAR-35205000
Industry P/E16.8
Technical Analysis
TrendBearish
RSI47.1
SupportSAR 8.94
ResistanceSAR 9.46
MA 20SAR 9.26
MA 50SAR 9.36
MA 200SAR 10.02
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta0.32
Volatility23.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.